- Chemical diversity and biological activities of the saponins isolated from Astragalus genus: focus on Astragaloside IV
Vittoria Graziani et al, 2019, Phytochemistry Reviews CrossRef - New Insights into the Mechanisms of Chinese Herbal Products on Diabetes: A Focus on the “Bacteria-Mucosal Immunity-Inflammation-Diabetes” Axis
Zezheng Gao et al, 2017, Journal of Immunology Research CrossRef - Astragaloside IV ameliorates neuroinflammation-induced depressive-like behaviors in mice via the PPARγ/NF-κB/NLRP3 inflammasome axis
Mei-ting Song et al, 2018, Acta Pharmacologica Sinica CrossRef - Astragaloside IV Regulates Insulin Resistance and Inflammatory Response of Adipocytes via Modulating MIR-21/PTEN/PI3K/AKT Signaling
Xuxi Guo et al, 2023, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef - A review of saponin intervention in metabolic syndrome suggests further study on intestinal microbiota
Zichen Luo et al, 2020, Pharmacological Research CrossRef - HPLC-MS and Network Pharmacology Analysis to Reveal Quality Markers of Huo-Xue-Jiang-Tang Yin, a Chinese Herbal Medicine for Type 2 Diabetes Mellitus
Qiugu Chen et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef - Treatment with astragaloside IV reduced blood glucose, regulated blood lipids, and protected liver function in diabetic rats
Dong Han, 2021, Journal of International Medical Research CrossRef - Salvia miltiorrhiza in diabetes: A review of its pharmacology, phytochemistry, and safety
Qiangqiang Jia et al, 2019, Phytomedicine CrossRef - Could Cyclosiversioside F Serve as a Dietary Supplement to Prevent Obesity and Relevant Disorders?
Siqi Qin et al, 2023, International Journal of Molecular Sciences CrossRef - The regulatory role of dietary factors in skeletal muscle development, regeneration and function
Liyi Wang et al, 2022, Critical Reviews in Food Science and Nutrition CrossRef - Baicalin ameliorates polycystic ovary syndrome through AMP-activated protein kinase
Wei Wang et al, 2019, Journal of Ovarian Research CrossRef - Astragaloside IV inhibits protein tyrosine phosphatase 1B and improves insulin resistance in insulin-resistant HepG2 cells and triglyceride accumulation in oleic acid (OA)-treated HepG2 cells
Xiao Zhou et al, 2021, Journal of Ethnopharmacology CrossRef - Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?
Milton Packer, 2023, European Journal of Heart Failure CrossRef - The PI3K/Akt signaling axis and type 2 diabetes mellitus (T2DM): From mechanistic insights into possible therapeutic targets
Rana Taheri et al, 2024, Cell Biology International CrossRef - Astragaloside IV Inhibits Triglyceride Accumulation in Insulin-Resistant HepG2 Cells via AMPK-Induced SREBP-1c Phosphorylation
Chunyi Wang et al, 2018, Frontiers in Pharmacology CrossRef - Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects
Jianqin Zhang et al, 2020, Pharmacological Advances in Natural Product Drug Discovery CrossRef - Total Astragalus saponins can reverse type 2 diabetes mellitus-related intestinal dysbiosis and hepatic insulin resistance in vivo
Leilei Ma et al, 2023, Frontiers in Endocrinology CrossRef - Exercise-Induced Browning of White Adipose Tissue and Improving Skeletal Muscle Insulin Sensitivity in Obese/Non-obese Growing Mice: Do Not Neglect Exosomal miR-27a
Dongxue Wang et al, 2022, Frontiers in Nutrition CrossRef - The Molecular Basis of the Anti-Inflammatory Property of Astragaloside IV for the Treatment of Diabetes and Its Complications
Lin Li et al, 2023, Drug Design, Development and Therapy CrossRef - Variations in the insulin receptor substrate 1 (IRS1) and its association with growth traits in Chinese black Tibetan sheep (Ovis aries)
Li Zhou et al, 2021, Animal Biotechnology CrossRef - Regulatory effects of the AMPKα-SIRT1 molecular pathway on insulin resistance in PCOS mice: An in vitro and in vivo study
Xin Tao et al, 2017, Biochemical and Biophysical Research Communications CrossRef - Astragaloside IV Regulates Insulin Resistance and Inflammatory Response of Adipocytes via Modulating CTRP3 and PI3K/AKT Signaling
Yue Zhang et al, 2022, Diabetes Therapy CrossRef - Hotspot Analysis of Traditional Drugs in Diabetes Treatment Literature
Hui Shen et al, 2021, Chinese Journal of Integrative Medicine CrossRef - Therapeutic Mechanisms of Herbal Medicines Against Insulin Resistance: A Review
Jun Li et al, 2019, Frontiers in Pharmacology CrossRef - Identification and characterization of proteins that are differentially expressed in adipose tissue of olanzapine-induced insulin resistance rat by iTRAQ quantitative proteomics
Ni Yang et al, 2020, Journal of Proteomics CrossRef